Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1998 Jun;15(6):889-96.
doi: 10.1023/a:1011976615750.

In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2

Affiliations
Comparative Study

In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2

V P Shah et al. Pharm Res. 1998 Jun.

Abstract

Purpose: To describe the properties of the similarity factor (f2) as a measure for assessing the similarity of two dissolution profiles. Discuss the statistical properties of the estimate based on sample means.

Methods: The f2 metrics and the decision rule is evaluated using examples of dissolution profiles. The confidence interval is calculated using bootstrapping method. The bias of the estimate using sample mean dissolution is evaluated.

Results: 1. f2 values were found to be sensitive to number of sample points, after the dissolution plateau has been reached. 2. The statistical evaluation of f2 could be made using 90% confidence interval approach. 3. The statistical distribution of f2 metrics could be simulated using 'Bootstrap' method. A relatively robust distribution could be obtained after more than 500 'Bootstraps'. 4. A statistical 'bias correction' was found to reduce the bias.

Conclusions: The similarity factor f2 is a simple measure for the comparison of two dissolution profiles. But the commonly used similarity factor estimate f2 is a biased and conservative estimate of f2. The bootstrap approach is a useful tool to simulate the confidence interval.

PubMed Disclaimer

References

    1. Pharm Res. 1987 Oct;4(5):416-9 - PubMed
    1. Pharm Res. 1996 Dec;13(12):1799-803 - PubMed
    1. J Pharm Sci. 1997 Jun;86(6):690-700 - PubMed
    1. J Biopharm Stat. 1997 May;7(2):241-58 - PubMed
    1. Adv Exp Med Biol. 1997;423:269-88 - PubMed

Publication types

LinkOut - more resources